Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates (2020)

First Author: Stamatis C
Attributed to:  FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.22541/au.158861421.10410013

Publication URI: http://dx.doi.org/10.22541/au.158861421.10410013

Type: Preprint